Meptazinol hydrochloride 25 mg | Purity Not Available
TargetMol
Meptazinol Hcl, a unique centrally opioid analgesic, is used as a narcotic antagonist with analgesic properties.
More Information Supplier PageMeptazinol hydrochloride
Search Results
Citiolone 100 mg | 99.78%
TargetMol
Citiolone, a drug used in liver treatment, is a derivative of the amino acid cysteine.
More Information Supplier PageCitiolone
Actarit 100 mg | Purity Not Available
TargetMol
Actarit
Isoxicam 200 mg | 99.12%
TargetMol
Isoxicam is a non-steroidal anti-inflammatory drug that is not marketed in the United States.
More Information Supplier PageIsoxicam
Mefexamide 200 mg | 99.78%
TargetMol
Mefexamide
Chloropyramine hydrochloride 200 mg | 99.45%
TargetMol
Chloropyramine hydrochloride
Prasugrel 200 mg | 98.62%
TargetMol
Prasugrel is a piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.
More Information Supplier PagePrasugrel
Meptazinol hydrochloride 200 mg | Purity Not Available
TargetMol
Meptazinol Hcl, a unique centrally opioid analgesic, is used as a narcotic antagonist with analgesic properties.
More Information Supplier PageMeptazinol hydrochloride
Leucomethylene blue mesylate 50 mg | Purity Not Available
TargetMol
Leucomethylene blue mesylate (TRx0237 mesylate) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer’s disease (AD) and frontotemporal dementia.
More Information Supplier PageLeucomethylene blue mesylate
Leucomethylene blue mesylate 10 mg | Purity Not Available
TargetMol
Leucomethylene blue mesylate (TRx0237 mesylate) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer’s disease (AD) and frontotemporal dementia.
More Information Supplier PageLeucomethylene blue mesylate